# Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

> **NCT05590793** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 195 (actual)

## Conditions studied

- Advanced Prostate Cancer
- Metastatic Prostate Cancer
- Locally Advanced Prostate Cancer

## Interventions

- **DRUG:** Triptorelin pamoate (embonate) salt

## Key facts

- **NCT ID:** NCT05590793
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-17
- **Primary completion:** 2024-08-20
- **Final completion:** 2024-08-20
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590793, "Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05590793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*